Osaka, Japan

Masahiro Mizuno



Average Co-Inventor Count = 6.3

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Mishima-gun, JP (2005)
  • Osaka, JP (2013 - 2023)

Company Filing History:


Years Active: 2005-2023

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Masahiro Mizuno: Innovator in Pharmaceutical Chemistry

Introduction

Masahiro Mizuno is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target cell division and cancer treatment. With a total of four patents to his name, Mizuno's work is recognized for its potential impact on medical science.

Latest Patents

Mizuno's latest patents include innovative formulations and processes related to a compound known as 2-[(2S)-1-azabicyclo[2.2.2]oct-2-yl]-6-(3-methyl-1H-pyrazol-4-yl)thieno[3,2-d]pyrimidin-4(3H)-one hemihydrate. This patent details the crystalline forms of the compound, methods for preparing these forms, and their applications in pharmaceutical compositions. Additionally, he has developed processes for synthesizing this compound, which serves as a Cdc7 kinase inhibitor, useful in treating disorders related to cell proliferation, particularly cancer.

Career Highlights

Mizuno is currently associated with Takeda Pharmaceutical Company Limited, where he continues to advance his research and development efforts. His work has been instrumental in creating new therapeutic options for patients suffering from various forms of cancer. His innovative approach to pharmaceutical chemistry has garnered attention in the scientific community.

Collaborations

Mizuno has collaborated with notable colleagues, including Kazuhiro Maeda and Tsuneo Yasuma. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the quality and impact of their research.

Conclusion

Masahiro Mizuno's contributions to pharmaceutical chemistry exemplify the importance of innovation in the fight against cancer. His patents and ongoing research continue to pave the way for new treatments that could significantly improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…